WASHINGTON — The Senate is taking pains to keep away from one other Aduhelm controversy.
In new bipartisan legislation unveiled on Friday, senators included language that will create a “coordinating council” meant to make sure officers throughout your entire Meals and Drug Administration keep in sync when contemplating medicines beneath the controversial accelerated approval pathway.
